Our Transparency Policy

Our Transparency Policy

Our Transparency Policy pattern
image undefined

Our Commitment

Gilead is committed to making information about our clinical research publicly available. We believe that transparency advances science and medicine and is in the best interest of the individuals who use our products and providers who prescribe them.

  • We strive to ensure that our research practices are transparent, responsible and fully compliant with applicable laws and regulations.

  • We have staff dedicated to ensuring the timely registration of clinical trials, communication of research results and release of clinical trial documents.

  • We collaborate with external medical experts and scientific researchers to advance clinical research and enhance public health.

Gilead provides this information consistent with the need to protect patient privacy, publication rights and proprietary information. Details regarding Gilead’s pipeline of investigational medicinal products can be found at http://www.Gilead.com/research/pipeline. Additional information regarding specific Gilead clinical trials can be found on publicly accessible registries, including www.ClinicalTrials.gov (CTgov) and www.ClinicalTrialsRegister.eu (EU-CTR).

If you have a specific inquiry regarding Gilead’s Clinical Trial Disclosure and Data Transparency commitment or practices, please contact us at [email protected]

sliderIcon

Clinical Trial Registration

sliderIcon

Clinical Trial Registration

Gilead registers clinical trials on clinical trial registries such as ClinicalTrials.gov (CTgov) and www.clinicaltrialsregister.eu (EU-CTR) as required by law and/or regulation, and in accordance with local requirements.

Gilead ensures that applicable clinical trials are registered prior to the first patient being consented for the study. Registration prior to first patient consent is aligned with the International Committee of Medical Journal Editors (ICMJE) guidelines.